3-48857132-TA-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_000387.6(SLC25A20):c.*577delT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00243 in 145,974 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0013 ( 1 hom., cov: 31)
Exomes 𝑓: 0.065 ( 0 hom. )
Consequence
SLC25A20
NM_000387.6 3_prime_UTR
NM_000387.6 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.539
Genes affected
SLC25A20 (HGNC:1421): (solute carrier family 25 member 20) This gene product is one of several closely related mitochondrial-membrane carrier proteins that shuttle substrates between cytosol and the intramitochondrial matrix space. This protein mediates the transport of acylcarnitines into mitochondrial matrix for their oxidation by the mitochondrial fatty acid-oxidation pathway. Mutations in this gene are associated with carnitine-acylcarnitine translocase deficiency, which can cause a variety of pathological conditions such as hypoglycemia, cardiac arrest, hepatomegaly, hepatic dysfunction and muscle weakness, and is usually lethal in new born and infants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAdExome4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0628 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A20 | ENST00000319017 | c.*577delT | 3_prime_UTR_variant | Exon 9 of 9 | 1 | NM_000387.6 | ENSP00000326305.4 | |||
SLC25A20 | ENST00000430379 | c.*577delT | 3_prime_UTR_variant | Exon 7 of 7 | 3 | ENSP00000388986.1 | ||||
SLC25A20 | ENST00000479050.1 | n.*108delT | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00133 AC: 191AN: 143432Hom.: 1 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
191
AN:
143432
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0651 AC: 163AN: 2502Hom.: 0 Cov.: 0 AF XY: 0.0620 AC XY: 81AN XY: 1306 show subpopulations
GnomAD4 exome
AF:
AC:
163
AN:
2502
Hom.:
Cov.:
0
AF XY:
AC XY:
81
AN XY:
1306
Gnomad4 AFR exome
AF:
AC:
0
AN:
14
Gnomad4 AMR exome
AF:
AC:
34
AN:
630
Gnomad4 ASJ exome
AF:
AC:
0
AN:
12
Gnomad4 EAS exome
AF:
AC:
2
AN:
38
Gnomad4 SAS exome
AF:
AC:
12
AN:
232
Gnomad4 FIN exome
AF:
AC:
0
AN:
10
Gnomad4 NFE exome
AF:
AC:
109
AN:
1472
Gnomad4 Remaining exome
AF:
AC:
6
AN:
94
⚠️ The allele balance in gnomAD4 Exomes is highly skewed (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Heterozygous variant carriers
0
18
36
54
72
90
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00133 AC: 191AN: 143472Hom.: 1 Cov.: 31 AF XY: 0.00144 AC XY: 100AN XY: 69516 show subpopulations
GnomAD4 genome
AF:
AC:
191
AN:
143472
Hom.:
Cov.:
31
AF XY:
AC XY:
100
AN XY:
69516
Gnomad4 AFR
AF:
AC:
0.0019573
AN:
0.0019573
Gnomad4 AMR
AF:
AC:
0.00119399
AN:
0.00119399
Gnomad4 ASJ
AF:
AC:
0.000590667
AN:
0.000590667
Gnomad4 EAS
AF:
AC:
0.000606061
AN:
0.000606061
Gnomad4 SAS
AF:
AC:
0.00353826
AN:
0.00353826
Gnomad4 FIN
AF:
AC:
0.00263098
AN:
0.00263098
Gnomad4 NFE
AF:
AC:
0.000767177
AN:
0.000767177
Gnomad4 OTH
AF:
AC:
0.00154162
AN:
0.00154162
Heterozygous variant carriers
0
8
16
23
31
39
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Carnitine acylcarnitine translocase deficiency Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at